An interview with Intel CEO Pat Gelsinger on having had “some serious” leadership, people, and methodology issues, the rough turnaround, competitors, and more
Context & Ripple Effects
When Pat Gelsinger returned to Intel, the bet was IDM 2.0: keep designing in-house, partner with TSMC where capacity demanded it, buy Tower Semiconductor, and treat AMD's rise as the playbook to reverse. Two years in, he was telling the Journal the blockers weren't just process nodes — Intel had “serious issues” in leadership, people, and methodology, a candid organizational diagnosis at the midpoint of a turnaround whose hardest phase, the foundry push and 18A, was still ahead.
The rest of the arc validates how consequential that admission was: by late 2024 investors had lost confidence in him and he was out, with retrospectives tallying what the bet cost. His own ex-CEO verdict blamed “decay” and the CHIPS Act's terrible execution — yet his successor Lip-Bu Tan is broadly running the same strategy, now focused on instilling the urgency Gelsinger said was missing.
First-order effects
- For Intel itself, naming people-and-methodology problems shifts the turnaround's binding constraint from technology to organization — precisely the territory Lip-Bu Tan's later urgency-building effort targets.
- Competitors Gelsinger explicitly studied, AMD chief among them, get a longer window in which Intel's product cadence competes against a company simultaneously fixing its own management layer.
Second-order effects
- Prospective foundry customers — the “reluctant” ones Gelsinger later discussed alongside partners like Amazon — now price execution risk into whether they commit, making internal-culture repair a sales prerequisite rather than an HR exercise.
- Mounting costs plus visible leadership turmoil feed the investor-confidence erosion that ultimately ended Gelsinger's tenure, tightening the feedback loop between turnaround spending and market patience.
Third-order effects
- If the pattern holds, chipmaker turnarounds are multi-CEO projects where strategy outlives its author — Tan continuing Gelsinger's plan suggests boards will swap leaders before abandoning capital-intensive bets.
- Public funding becomes part of the credibility equation: Gelsinger's own criticism of CHIPS Act execution signals that future programs will be judged on delivery discipline, not disbursement.
The trend: Semiconductor turnarounds are stretching into decade-scale, multi-CEO endeavors in which strategy continuity persists across leadership changes while execution credibility — talent, cadence, and government money — decides who wins.